These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3581681)

  • 1. Beta-adrenoceptor blockade and plasma lipoproteins. Comparison of the effects of propranolol and pindolol on plasma lipoproteins including high-density lipoprotein subfractions.
    Northcote RJ; Ballantyne D
    Clin Sci (Lond); 1987 May; 72(5):549-56. PubMed ID: 3581681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease.
    Murphy MB; Sugrue D; Trayner I; Kaufman S; Yasuhara H; Dollery CT; Thompson GR
    Br Heart J; 1984 Jun; 51(6):589-94. PubMed ID: 6732988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men.
    Durrington PN; Brownlee WC; Large DM
    Clin Sci (Lond); 1985 Dec; 69(6):713-9. PubMed ID: 2866062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of angina pectoris with pindolol: the significance of intrinsic sympathomimetic activity of beta blockers.
    Kostis JB; Frishman W; Hosler MH; Thorsen NL; Gonasun L; Weinstein J
    Am Heart J; 1982 Aug; 104(2 Pt 2):496-504. PubMed ID: 7102536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind trial of the long-term effects of acebutolol and propranolol on serum lipoproteins in patients with stable angina pectoris.
    Miller NE; Nanjee MN; Rajput-Williams J; Coltart DJ
    Am Heart J; 1987 Oct; 114(4 Pt 2):1007-10. PubMed ID: 3310569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs in the treatment of patients with angina pectoris.
    Harry JD
    Bibl Cardiol; 1976; (35):172-82. PubMed ID: 10882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pindolol versus atenolol on lipid profile in hypertensive patients.
    Notghi A; Riemersma RA; Anderton JL; Oliver MF
    Atherosclerosis; 1989 Jun; 77(2-3):215-20. PubMed ID: 2751753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of pindolol.
    Aellig WH
    Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of pindolol and propranolol on exercise performance in patients with angina pectoris.
    Magder S; Sami M; Ripley R; Lisbona R
    Am J Cardiol; 1987 Jun; 59(15):1289-94. PubMed ID: 3591681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of verapamil on serum lipoproteins in patients with angina pectoris.
    Walldius G
    Acta Med Scand Suppl; 1984; 681():43-8. PubMed ID: 6587755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of intrinsic sympathomimetic activity on respiratory function during chronic beta blockade: comparison of propranolol and pindolol.
    Northcote RJ; Ballantyne D
    Br Med J (Clin Res Ed); 1986 Jul; 293(6539):97-9. PubMed ID: 3089433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pindolol and propranolol in patients with angina pectoris and normal or near-normal ventricular function. Lack of influence of intrinsic sympathomimetic activity on global and segmental left ventricular function assessed by radionuclide ventriculography.
    Manyari DE; Kostuk WJ; Carruthers SG; Johnston DJ; Purves P
    Am J Cardiol; 1983 Feb; 51(3):427-33. PubMed ID: 6401908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the onset of the antihypertensive action of pindolol and propranolol. A 24 h haemodynamic study.
    van den Meiracker AH; Man in't Veld AJ; Schalekamp MA
    Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):39S-44S. PubMed ID: 3326634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pindolol on serum lipoproteins in patients with coronary heart disease.
    Karmakoski J; Viikari J; Rönnemaa T
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):189-91. PubMed ID: 6862723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of metoprolol and pindolol monotherapy on plasma lipid- and lipoprotein-cholesterol levels (including the HDL subclasses) in mild hypertensive males and females.
    Szollár LG; Mészáros I; Tornóci L; Rischák K; Molnár M; Mányai S
    J Cardiovasc Pharmacol; 1990 Jun; 15(6):911-7. PubMed ID: 1694913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of intrinsic sympathomimetic activity on regional left ventricular function; use of regional ejection fraction to demonstrate a beneficial action by pindolol over propranolol on hypokinetic segments.
    Johnston DL; Manyari DE; Kostuk WJ
    Can J Cardiol; 1985; 1(3):174-9. PubMed ID: 2996726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acute effect of prolonged walking and dietary changes on plasma lipoprotein concentrations and high-density lipoprotein subfractions.
    Griffin BA; Skinner ER; Maughan RJ
    Metabolism; 1988 Jun; 37(6):535-41. PubMed ID: 3163762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein changes in children after liver transplantation: mild hypertriglyceridemia and a decrease in HDL3/HDL2 ratio.
    Granot E
    Hepatology; 1998 Jan; 27(1):175-80. PubMed ID: 9425934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of beta blockers on blood lipid profile.
    Lehtonen A
    Am Heart J; 1985 May; 109(5 Pt 2):1192-6. PubMed ID: 2859784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the effects of beta-blockers with and without intrinsic sympathomimetic activity on hemodynamics and left ventricular function at rest and during exercise in patients with coronary artery disease.
    Choong CY; Roubin GS; Harris PJ; Tokuyasu Y; Shen WF; Bautovich GJ; Kelly DT
    J Cardiovasc Pharmacol; 1986; 8(3):441-8. PubMed ID: 2425156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.